Oxford/AstraZeneca jab should not be given to over 65s, says Germany

The vaccine commission of Germany said that it could not recommend the use of AstraZeneca’s coronavirus vaccine for older people. The panel which consisted of scientific experts said that the vaccine should only be given to people aged 18 to 65 years old. It said ’there is currently insufficient data to assess the efficacy of the vaccine for persons aged 65 years and older’.

Oxford/AstraZeneca jab should not be given to over 65s, says Germany

SNP wins election, plans second referendum on independence

’Mystery boxes’ in China discovered with suffocating pups and kittens inside

US Navy seizes weapons in Arabian Sea likely bound for Yemen

Chinese Rocket landed in the Indian Ocean

Thai court verdict to allow a minister to keep his role despite drug punishment

Palestinians fear loss of family homes as evictions loom

Yair Lapid is in charge to try to form next Israeli government

Chinese government’s order might affect Hollywood movie market in China

Remains of nine Neanderthals found in cave south of Rome

Giant mining company Rio Tinto was protested after sacred cave excavation

Tonnes of fish dead due to high level pollution in Lebanese lake

PM Narendra Modi faces mounting calls for national lockdown amid COVID crisis

Bombing in Kabul kills at least 50

Sadiq Khan won the election for two years in a row

As Covid ravages India, PM Modi presses ahead with $1.8B parliament renovation

Kentucky Derby winner fails drugs test

More than 200 injured in Palestinian protests

Street preacher arrested for holding Saturday gathering in Calgary

25 dead, 52 injured after explosion near Afghan school in Kabul

Scotland’s pro-independence party moves closer to a majority

Major US pipeline shut by ransomware attack

Why the Covid vaccination program in the Torres Strait islands depends on trust

India’s COVID-19 surge negatively effects neighboring countries

Palestinians and Israeli police clash at Jerusalem’s Al-Aqsa mosque

Key EU countries rebuff Biden on sharing COVID-19 vaccine patents